Sofinnova Investments, Inc. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$32,457,356
+107.9%
2,045,202
+147.2%
2.05%
+100.1%
Q2 2023$15,611,491
+111.2%
827,318
-57.0%
1.02%
+116.3%
Q1 2023$7,390,203
-11.6%
1,924,532
+14.1%
0.47%
-4.6%
Q4 2022$8,363,324
+248.3%
1,686,154
+235.6%
0.50%
+254.3%
Q3 2022$2,401,000
-53.2%
502,393
-56.0%
0.14%
-67.3%
Q2 2022$5,134,000
-24.5%
1,140,788
-20.1%
0.43%
-17.1%
Q1 2022$6,798,000
-47.6%
1,428,169
-18.4%
0.52%
-31.9%
Q4 2021$12,984,000
+3098.0%
1,749,882
+1066.6%
0.76%
+1843.6%
Q1 2019$406,000
-81.1%
150,000
-66.4%
0.04%
-85.4%
Q4 2018$2,146,000447,0750.27%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders